![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/SUNLOC.png)
Share the post "Sunil Healthcare ‘s Latest Q2 Report: Profit Up by 50% Year-on-Year"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company’s sales declined by -14.53 % over the year, decrease in net sales/revenue by -5.76 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -19.55 %, Marginal increase in other income during this quarter, up by 25.53%.
- Profit over the Year and quarter: Challenges in sustaining profitability for Sunil Healthcare Limited. Profit dropped by -50.14 % Year to Year, Sunil Healthcare Limited’s profitability dropped by -20.69 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -50.47 % Year to Year. EPS decreased by -20.9 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 23.702 Cr | Rs. 21.496 Cr | Rs. 20.258 Cr | -5.76 % | -14.53 % |
| Expenses | Rs. 22.48 Cr | Rs. 19.28 Cr | Rs. 17.94 Cr | -6.95 % | -20.2 % |
| Operating Profit | Rs. 1.22 Cr | Rs. 2.22 Cr | Rs. 2.32 Cr | + 4.5 % | + 90.16 % |
| OPM % | 5.15 % | 10.33 % | 11.45 % | + 1.12 % | + 6.3 % |
| Other Income | Rs. 0.22 Cr | Rs. 0.141 Cr | Rs. 0.177 Cr | + 25.53 % | -19.55 % |
| Interest | Rs. 1.31 Cr | Rs. 1.52 Cr | Rs. 1.5 Cr | -1.32 % | + 14.5 % |
| Depreciation | Rs. 1.59 Cr | Rs. 1.49 Cr | Rs. 1.51 Cr | + 1.34 % | -5.03 % |
| Profit before tax | Rs. -1.46 Cr | Rs. -0.65 Cr | Rs. -0.51 Cr | + 21.54 % | + 65.07 % |
| Tax % | -24.78 % | -6.96 % | -6.82 % | + 0.14 % | + 17.96 % |
| Net Profit | Rs. -1.1 Cr | Rs. -0.69 Cr | Rs. -0.55 Cr | + 20.29 % | + 50 % |
| EPS in Rs | Rs. -1.07 | Rs. -0.67 | Rs. -0.53 | + 20.9 % | + 50.47 % |
Today, we’re looking at Sunil Healthcare Limited’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a significant year-over-year sales decline of -14.53 %. However, it did see a marginal slip of -5.76 % from the previous quarter. Expenses decreased slightly by -6.95 % quarter-on-quarter, aligning with the annual decline of -20.2 %. Operating profit, while up 90.16 % compared to last year, faced a quarter-on-quarter increase of 4.5 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 6.3 %, but an expansion of 1.12 % sequentially. Other income rose by 25.53 % compared to the last quarter, despite an annual decline of -19.55 %. Interest expenses dropped significantly by -1.32 % from the previous quarter, yet the year-over-year increase remains at a moderate 14.5 %. Depreciation costs climbed by 1.34 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -5.03 %. Profit before tax grew annually by 65.07 % but saw an increase from the preceding quarter by 21.54 %.
Tax expenses as a percentage of profits increased slightly by 17.96 % compared to last year, with a more notable quarter-on-quarter increase of 0.14 %. Net profit rose by 50 % year-on-year but experienced a 20.29 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 50.47 % but a quarterly rise of 20.9 %. In summary, Sunil Healthcare Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 23.702 Cr | Rs. 21.496 Cr | Rs. 20.258 Cr | -5.76 % | -14.53 % |
| Expenses | Rs. 22.48 Cr | Rs. 19.28 Cr | Rs. 17.94 Cr | -6.95 % | -20.2 % |
| Operating Profit | Rs. 1.22 Cr | Rs. 2.22 Cr | Rs. 2.32 Cr | + 4.5 % | + 90.16 % |
| Net Profit | Rs. -1.1 Cr | Rs. -0.69 Cr | Rs. -0.55 Cr | + 20.29 % | + 50 % |
| EPS in Rs | Rs. -1.07 | Rs. -0.67 | Rs. -0.53 | + 20.9 % | + 50.47 % |
In reviewing Sunil Healthcare Limited’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -14.53 % year-on-year, although there was a slight dip of -5.76 % from the previous quarter. Expenses decreased by -20.2 % compared to the previous year, with a decrease of -6.95 % quarter-on-quarter. Operating Profit surged by 90.16 % annually, and saw a 4.5 % increase from the last quarter.
Net Profit showed yearly increase of 50 %, and experienced a 20.29 % increase from the previous quarter. Earnings Per Share (EPS) rose by 50.47 % annually, however rose by 20.9 % compared to the last quarter. In essence, while Sunil Healthcare Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”Sunil Healthcare Limited”]
